Graduate Programme for Medical Doctors with clinical experience, Clinical Development
Are you looking for the next step to kick-start your transition from an early career in clinical practice to become a young professional within Clinical Development in a leading pharmaceutical company within brain disorders? Then we have the Graduate Programme just for you.
As part of your two-year graduate journey at Lundbeck you will be exposed to various parts of the business and you will encounter many exciting challenges cross-functionally. The learning curve will be steep and we expect a lot from you, but in return we offer a programme that will empower you to grow both on a professional and personal level.
Clinical Development at Lundbeck
Clinical Development is responsible for the planning, conduct and evaluation of clinical studies. Our therapy areas consist of Psychiatry and Neurology. The position is based within the Depression & Paediatrics Group at Lundbeck’s headquarters in Valby, Copenhagen.
Your job and the journey
We are searching for a graduate who can support Clinical Development in the daily work, while developing professional and personal skills and expertise for a career in drug development. You will report to and work closely with the Head of Depression and Pediatrics. You will participate in clinical study teams and be interacting with multi-disciplinary project groups and work in close collaboration with partners in Research, Clinical and Quantitative Pharmacology, Biostatistics and Programming, and Clinical Study Management.
For you to learn as much as possible about drug development, the Graduate Programme includes periods of job rotation to other relevant areas in Lundbeck. During the programme, you will also participate in a wide range of development activities on your own as well as with other graduates across the entire value chain – everything designed to guide you through the programme, making sure you are on track and able to unfold your potential.
The position might include travel activities.
Our preferred graduate has the following qualifications:
- A Medical Doctor (M.D.) degree
- 2-5 years of clinical experience as a physician
- PhD is not a requirement but will be considered a plus
- Excellent academic achievements and English language skills
- You have the ambition to push yourself to achieve results
- You are eager to learn, contribute and apply knowledge
- You build partnerships and work collaboratively with others to meet shared objectives
- You actively seek new ways to grow and to be challenged using both formal and informal development channels
Join our Open House event on 4 April 2018 at Lundbeck in Valby. Here you will get a chance to interact with managers from the relevant areas and hear more about the positions. Read more and sign up for the event on our website: http://www.lundbeck.com/global/career/graduate-programme
If you could not find the answer to your question on our website, do not hesitate to send an email to firstname.lastname@example.org.
Please click on the link to apply for the job. Applications must be received no later than 8 April 2018. In addition to completing the application, you must record a 1-minut video introducing yourself and explaining your motivation for Lundbeck and the Graduate Programme. We look forward to receiving your application.
Lundbeck is a global pharmaceutical company highly committed to improving the quality of life of people living with psychiatric and neurological disorders. For this purpose, Lundbeck is engaged in the research, development, production, marketing and sale of pharmaceuticals across the world. The company’s products are targeted at the disease areas depression, schizophrenia, Parkinson’s disease and Alzheimer’s disease.
Lundbeck employs approximately 5,000 people worldwide. We have employees in more than 50 countries, and our products are registered in more than 100 countries. We have production facilities in Denmark, France and Italy and our research centre is based in Denmark. Lundbeck generated revenue of approximately DKK 17.2 billion in 2017.